a. Who Good
Manufacturing Practices (GMP)
Good manufacturing practice (GMP) is that part of
quality assurance which ensures that products are consistently produced and
controlled to the quality standards appropriate to their intended use and as
required by the marketing authorization.
GMP is aimed primarily at diminishing the risks
inherent in any pharmaceutical production, which may broadly be categorized in
two groups: cross contamination/mix-ups and false labelling.
Above all, manufacturers must not place patients at
risk due to inadequate safety, quality or efficacy; for this reason, risk assessment
has come to play an important role in WHO quality assurance guidelines.
b. Good Laboratory Practices (GLP)
GLP specifically refers to a quality system of
management controls for research laboratories and organizations to
try to ensure the uniformity, consistency, reliability, reproducibility,
quality, and integrity of chemical (including pharmaceuticals) safety and
efficacy tests. GLP was instituted following cases of animal test fraud by
pharmaceutical and industrial chemical (mainly pesticide) manufacturers.
c. Good Clinical Practices (GCP)
Good Clinical Practice is an international
quality standard that is provided by International Conference on
Harmonisation (ICH) that defines standards, which governments can transpose
into regulations for clinical trials involving human subjects.
Good Clinical Practice guidelines include
protection of human rights as a subject in clinical trial. It also provides
assurance of the safety and efficacy of the newly developed compounds.
d. International Organisation for Standardization
(ISO)
The International Organization for
Standardization, widely known as ISO, is an international
standard-setting body composed of representatives from various
national standards organizations.
While ISO defines itself as a non-governmental
organization, its ability to set standards that often become law, either
through treaties or national standards, makes it more powerful than
most non-governmental organizations.
No comments:
Post a Comment